Kearney Terrence C 4
4 · VERTEX PHARMACEUTICALS INC / MA · Filed May 3, 2024
Insider Transaction Report
Form 4
Kearney Terrence C
Director
Transactions
- Award
Stock Option (Right to Buy)
2024-05-01+3,142→ 3,142 totalExercise: $399.71Exp: 2034-04-30→ Common Stock (3,142 underlying)
Footnotes (1)
- [F1]Fully vested.